The HHS inspector general’s office is estimating that taxpayers overpaid for the EpiPen by as much as $1.27 billion between 2006 and 2016.
Source: Drug Industry Daily
The HHS inspector general’s office is estimating that taxpayers overpaid for the EpiPen by as much as $1.27 billion between 2006 and 2016.
Source: Drug Industry Daily